PE Tech Report


Like this article?

Sign up to our free newsletter

Good Growth Capital closes fund III at over $100m

Good Growth Capital has closed its oversubscribed third fund at over $100 million in capital commitments.

The majority women- and minority-owned firm is known for investing early in complex technologies that are yielding top returns. Good Growth Capital’s first fund, a 2017 vintage, is tracking to earn top-decile returns. 

The firm also reports a double-bottom line as an impact investor, focusing on investing for the highest possible return while investing in companies that meet pressing societal needs. This new fund makes Good Growth Capital the largest venture capital fund in South Carolina history and one of the largest early-stage funds in the Southeast.

Good Growth Capital invests from pre-seed through to Series B investments in biomedical and health sciences, green tech, data, and physical and material sciences. Sixty per cent of the firm’s managing partners are female and 20 per cent are Latino, while more than 75 per cent of Good Growth Capital’s portfolio is led by founders from diverse backgrounds. 

Prior investments from Good Growth Capital that have reached valuations of over US $1 billion include SkyHawk Therapeutics, a drug discovery and development company; Republic, a regulated crowdfunding platform that matches startups to investors seeking early-stage equity investment opportunities; and an alternative energy investment that is still in stealth mode. 

Like this article? Sign up to our free newsletter